glp1 tirzepatide GLP-1 use tripled among non-diabetics, reaching $5.8B in 2022 Decoding GLP-1 Weight Loss Medications

Recalls & Warnings December 29, 2025 Rheumacare Capsules Recalled Due to Lead On December 22, 2025, Handelnine Global Limited (d.b.a

Starting at a lower dose and advancing slowlyrather than jumping to higher amounts immediatelyminimizes cramping risk for most patients

GLP-1 Weight Loss in Wilmington, NC - Done Right

We introduced a series of seminars for patients and healthcare professionals raising awareness about diagnosis and treatment of PA including important topics like iron deficiency We updated our website and information sheets We explored and continue to work on research projects for those issues identified in the NICE recommendations on B12 deficiency and in the James Lind Alliance Priority Setting Partnership